The Brazil therapeutic respiratory devices market was estimated at USD 0.35 billion in 2022 and it is expected to surpass around USD 0.66 billion by 2032, poised to grow at a CAGR of 6.53% from 2023 to 2032.
Key Pointers
Report Scope of the Brazil Therapeutic Respiratory Devices Market
Report Coverage | Details |
Market Size in 2022 | USD 0.35 billion |
Revenue Forecast by 2032 | USD 0.66 billion |
Growth rate from 2023 to 2032 | CAGR of 6.53% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Companies Covered | Koninklijke Philips NV; Medtronic; Masimo; Chart Industries; Hamilton Medical; BD (Becton, Dickinson and Company); ResMed Inc.; General Electric Company (GE HealthCare); Drägerwerk AG & Co. KGaA; Fisher & Paykel Healthcare Limited |
The use of respiratory devices is primarily focused on treating respiratory diseases such as asthma and COPD. With an increase in patient populations, the sales of respiratory devices have been growing. The aging population is also a contributing factor, as COPD is more common among older adults. According to a BMJ journal article from 2019, Brazil has a high incidence and prevalence of COPD, affecting around 8 million individuals. Over the forecast period, this is expected to drive the demand for therapeutic respiratory devices in the country. Furthermore, product types such as nebulizers and ventilators have many smaller to large-size competitors relative to other markets because these devices rely less on drug approvals, ultimately leading to supporting the market for further expansion. Market competitors continue to dominate through their strong relationships with physicians and the launch of new devices. For instance, according to April 2022, news event from CAIRE Inc., the company launched two new products, namely, Companion 5 and NewLife Intensity 10 Stationary Concentrators, in Brazil in July after receiving the go-ahead for from ANVISA, the Brazilian health regulatory agency.
The therapeutic respiratory devices market is boosted by government and private initiatives. For instance, in April 2020, Vyaire Medical secured a contract worth USD 50 million from the Brazilian Ministry of Health. The contract aimed to produce 4,300 iX5 ventilators by June 2020 to address the COVID-19 pandemic. This initiative highlights the vital role of respiratory devices in tackling the challenges posed by the COVID-19 pandemic.
The COVID-19 pandemic had a positive impact on the market to some extent. In several ways, the COVID-19 epidemic was beneficial for the market. Non-essential healthcare services and procedures were postponed or canceled initially due to shelter-in-place orders. However, connected care businesses saw an increase in demand, which was advantageous for major players in the industry. For instance, Philips N.V. reported positive growth in its connected care businesses during the first half of 2020, including the ventilator portfolio. The demand for COVID-19 has grown, which has contributed to this development. According to Philips N.V.'s 2020 annual report, despite the pandemic's overall effects on the company, it managed to grow comparable sales by 3% and produce a healthy cash flow of EUR 1.9 billion.
Therapeutic respiratory devices for home healthcare have drawn much attention from notable international manufacturers and growing vendors. For instance, Philips provides home ventilation options to demonstrate their dedication to conveniently serving patients in their homes. This emphasis on home healthcare reflects the rising understanding of the significance of patient access to easy respiratory care.
Product Insights
Based on product, the Brazil therapeutic respiratory devices market is segmented into nebulizers, humidifiers, oxygen concentrators, positive airway pressure devices, ventilators, gas analyzers, and capnographs. The oxygen concentrators segment accounted for a revenue share of 18% in 2022. This can be attributed to technological advancements in respiratory devices, increasing prevalence of respiratory diseases, growing demand for home oxygen therapy, a rise in the aging population, and high tobacco consumption, among other factors.
On the other hand, capnographs are anticipated to witness rapid growth at a CAGR of 10.53% during the forecast period. The use of capnography in treating respiratory disorders is anticipated to enhance the medical effectiveness of these devices for patient monitoring, owing to their increased reliability and efficacy.
Technology Type Insights
Based on technology type, the Brazil therapeutic respiratory devices market is segmented into electrostatic filtration, HEPA filter technology, hollow fiber filtration, and microsphere separation. The electrostatic filtration segment accounted for the highest revenue share of 36% in 2022. The increasing awareness of the importance of protection against air pollution has resulted in higher sales of electrostatic filtration products. Additionally, governments are investing in R&D to develop more advanced technologies suitable for commercial use, which is expected to drive the growth of this segment.
The HEPA filter segment holds the second position in the market. HEPA filters are widely used in various therapeutic respiratory devices for particle removal and retention. Compliance with CDC requirements necessitates the inclusion of HEPA filtration technology in therapeutic equipment for air filtration. The prevalence of respiratory disorders and the way they are transmitted are among the factors contributing to the demand for HEPA filters.
Filter Insights
Based on filter, the Brazil therapeutic respiratory devices market is segmented into nebulizer filters, humidifier filters, positive airway pressure device filters, oxygen concentrator filters, and ventilator filters. The increasing prevalence of respiratory diseases such as COPD and asthma, which are among the major factors driving the use of ventilators, is expected to have a significant impact on the ventilator filter market, accounting for 24% of revenue share in 2022. Additionally, it is anticipated that the market for homecare ventilators would benefit from the increase in demand for in-home healthcare, which will eventually have a beneficial impact on the ventilator filter market.
Using a humidifier increases air humidity and offers protection against environmental dryness. Demand for humidifier equipment is expected to rise as consumers become more aware of ailments including sinusitis, asthma, and specific allergies. As a result, it drives the growth of the humidifier filters market.
The humidifier filters segment is expected to grow rapidly with a CAGR of 7.92% during the forecast period. Increasing awareness of sinusitis, asthma, and allergies among consumers is driving the demand for humidifiers. These devices help increase air humidity and protect against dry environments. As a result, the market for humidifier filters is anticipated to expand.
Brazil Therapeutic Respiratory Devices Market Segmentations:
By Product
By Technology Type
By Filter
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Product Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Brazil Therapeutic Respiratory Devices Market
5.1. COVID-19 Landscape: Brazil Therapeutic Respiratory Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Brazil Therapeutic Respiratory Devices Market, By Product
8.1. Brazil Therapeutic Respiratory Devices Market, by Product, 2023-2032
8.1.1 Nebulizers
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Humidifiers
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Oxygen Concentrators
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Positive Airway Pressure Devices
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Ventilators
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. Gas Analyzers
8.1.6.1. Market Revenue and Forecast (2020-2032)
8.1.7. Capnographs
8.1.7.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Brazil Therapeutic Respiratory Devices Market, By Technology Type
9.1. Brazil Therapeutic Respiratory Devices Market, by Technology Type, 2023-2032
9.1.1. Electrostatic Filtration
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. HEPA Filter Technology
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Hollow Fiber Filtration
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Microsphere Separation
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Brazil Therapeutic Respiratory Devices Market, By Filter
10.1. Brazil Therapeutic Respiratory Devices Market, by Filter, 2023-2032
10.1.1. Nebulizer Filters
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Humidifier Filters
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. PAP Device Filters
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Oxygen Concentrator Filters
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Ventilator Filters
10.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Brazil Therapeutic Respiratory Devices Market, Regional Estimates and Trend Forecast
11.1. Brazil
11.1.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.2. Market Revenue and Forecast, by Technology Type (2020-2032)
11.1.3. Market Revenue and Forecast, by Filter (2020-2032)
Chapter 12. Company Profiles
12.1. Koninklijke Philips NV
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Medtronic.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Masimo.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Chart Industries.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Hamilton Medical
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. BD (Becton, Dickinson and Company)
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. ResMed Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. General Electric Company (GE HealthCare)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Drägerwerk AG & Co. KGaA.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Fisher & Paykel Healthcare Limited
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms